Literature DB >> 6285236

Vasopressin: a homeostatic effector in the febrile process.

N W Kasting, W L Veale, K E Cooper.   

Abstract

This review compares the physiological changes which accompany infection and fever with the effects of the peptide, arginine vasopressin (AVP). AVP may act as a neuromodulator, a releasing factor, or a hormone to induce responses which are opposite to those homeostatic changes accompanying fever. Since AVP is released into blood and brain during fever, it is hypothesized that AVP contributes to the maintenance of homeostasis in the infected organism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6285236     DOI: 10.1016/0149-7634(82)90057-4

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  5 in total

1.  Ultrastructural characterisation of vasopressinergic terminals in the lateral septum of murine brains by use of monoclonal anti-neurophysins.

Authors:  F D Shaw; M Castel; J F Morris
Journal:  Cell Tissue Res       Date:  1987-08       Impact factor: 5.249

2.  Effects of urethane, ambient temperature and injection route on rat body temperature and metabolism due to endotoxins.

Authors:  D C Bibby; R F Grimble
Journal:  J Physiol       Date:  1988-11       Impact factor: 5.182

3.  Comparison of the development of experimental pyelonephritis in homozygous brattleboro diabetes insipidus rats, heterozygous control rats and normal Wistar rats.

Authors:  M Güngör; O Anğ; V Uysal; H Sağduyu; D Inanç; M Anğ; H Koyuncuoğlu
Journal:  Infection       Date:  1985 Mar-Apr       Impact factor: 3.553

4.  Vasopressin-immunoreactive cell bodies in the bed nucleus of the stria terminalis of the rat.

Authors:  F van Leeuwen; R Caffé
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

5.  Stimulation of vasopressin release in the ventral septum of the rat brain suppresses prostaglandin E1 fever.

Authors:  A M Naylor; Q J Pittman; W L Veale
Journal:  J Physiol       Date:  1988-05       Impact factor: 5.182

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.